Seeing Is Believing
with an average price target of $365.49. This is a potential upside of $35.66 (10.81%) from yesterday's end of day stock price of $329.83.
Karuna Therapeutics's activity chart (see below) currently has 136 price targets and 83 ratings on display.
Analysts average stock forecasts to be materialized ratio is 92.85% with an average time for these price targets to be met of 209.87 days.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 20-Feb-2024. First documented stock forecast 22-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$330
$0.17 (0.05%)
$330
1 years 7 months 17 days ago
(20-Feb-2024)
2/4 (50%)
$11.41 (3.58%)
86
Hold
$245
$-84.83 (-25.72%)
$245
1 years 8 months 12 days ago
(25-Jan-2024)
12/13 (92.31%)
$-69 (-21.97%)
168
Buy
$295
$-34.83 (-10.56%)
$280
1 years 9 months 15 days ago
(22-Dec-2023)
2/3 (66.67%)
$-22.85 (-7.19%)
148
Hold
$227
$-102.83 (-31.18%)
$280
1 years 9 months 16 days ago
(21-Dec-2023)
4/5 (80%)
$-90.85 (-28.58%)
219
Buy
$330
$0.17 (0.05%)
$175
1 years 9 months 16 days ago
(21-Dec-2023)
4/5 (80%)
$12.15 (3.82%)
290
What is KRTX (Karuna Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KRTX (Karuna Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KRTX (Karuna Therapeutics)?
Which analyst is the currently most bullish on KRTX (Karuna Therapeutics)?
Which analyst is the currently most reserved on KRTX (Karuna Therapeutics)?